KRAS and cholangiocarcinoma: In a previous study of 20 biliary ITPNs, we found a surprisingly low prevalence of alterations of driver genes commonly affecting PDAC and CCA, including KRAS (mutated in 6%), GNAS, IDH1/2, and BRAF (0%) in both the intraductal and invasive tumor components [1].